{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:11:52Z","timestamp":1790863912947,"version":"4.1.0"},"reference-count":58,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Gene expression profiling of acute myeloid leukemia (AML) allows the discovery of previously unrecognized molecular entities. Here, we identified a specific subgroup of AML, defined by an expression profile resembling that of AMLs with mutations in the myeloid transcription factor CCAAT\/enhancer-binding protein alpha (C\/EBP\u03b1), while lacking such mutations. We found that in these leukemias, the CEBPA gene was silenced, which was associated with frequent promoter hypermethylation. The leukemias phenotypically showed aberrant expression of T-cell genes, of which CD7 was most consistent. We identified 2 mechanisms that may contribute to this phenotype. First, absence of Cebpa led to up-regulation of specific T-cell transcripts (ie, Cd7 and Lck) in hematopoietic stem cells isolated from conditional Cebpa knockout mice. Second, the enhanced expression of TRIB2, which we identify here as a direct target of the T-cell commitment factor NOTCH1, suggested aberrantly activated Notch signaling. Putatively activating NOTCH1 mutations were found in several specimens of the newly identified subgroup, while a large set of control AMLs was mutation negative. A gene expression prediction signature allowed the detection of similar cases of leukemia in independent series of AML.<\/jats:p>","DOI":"10.1182\/blood-2007-02-073486","type":"journal-article","created":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T21:11:44Z","timestamp":1186002704000},"page":"3706-3714","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":154,"title":["Distinct gene expression profiles of acute myeloid\/T-lymphoid leukemia with silenced CEBPA and mutations in NOTCH1"],"prefix":"10.1182","volume":"110","author":[{"given":"Bas J.","family":"Wouters","sequence":"first","affiliation":[{"name":"Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell Alberich","family":"Jord\u00e0","sequence":"additional","affiliation":[{"name":"Harvard Institutes of Medicine, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Keeshan","sequence":"additional","affiliation":[{"name":"Abramson Family Cancer Research Institute and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Louwers","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia A. J.","family":"Erpelinck-Verschueren","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"Tielemans","sequence":"additional","affiliation":[{"name":"Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton W.","family":"Langerak","sequence":"additional","affiliation":[{"name":"Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"He","sequence":"additional","affiliation":[{"name":"Abramson Family Cancer Research Institute and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumi","family":"Yashiro-Ohtani","sequence":"additional","affiliation":[{"name":"Abramson Family Cancer Research Institute and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Harvard Institutes of Medicine, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Hetherington","sequence":"additional","affiliation":[{"name":"Harvard Institutes of Medicine, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel G. W.","family":"Verhaak","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J. M.","family":"Valk","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"L\u00f6wenberg","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G.","family":"Tenen","sequence":"additional","affiliation":[{"name":"Harvard Institutes of Medicine, Boston, MA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warren S.","family":"Pear","sequence":"additional","affiliation":[{"name":"Abramson Family Cancer Research Institute and Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud","family":"Delwel","sequence":"additional","affiliation":[{"name":"Department of Hematology, Erasmus University Medical Center, Rotterdam, the Netherlands;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111712581273300_B1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1056\/NEJM199909303411407","article-title":"Acute myeloid leukemia.","volume":"341","author":"Lowenberg","year":"1999","journal-title":"N Engl J Med"},{"key":"2019111712581273300_B2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.moh.0000149610.14438.9a","article-title":"Gene expression profiling in acute myeloid leukemia.","volume":"12","author":"Valk","year":"2005","journal-title":"Curr Opin Hematol"},{"key":"2019111712581273300_B3","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1056\/NEJMoa031046","article-title":"Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.","volume":"350","author":"Bullinger","year":"2004","journal-title":"N Engl J Med"},{"key":"2019111712581273300_B4","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa040465","article-title":"Prognostically useful gene-expression profiles in acute myeloid leukemia.","volume":"350","author":"Valk","year":"2004","journal-title":"N Engl J Med"},{"key":"2019111712581273300_B5","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.1182\/blood-2004-03-1154","article-title":"Gene expression profiling of pediatric acute myelogenous leukemia.","volume":"104","author":"Ross","year":"2004","journal-title":"Blood"},{"key":"2019111712581273300_B6","doi-asserted-by":"crossref","first-page":"3747","DOI":"10.1182\/blood-2005-05-2168","article-title":"Mutations in nucleophosmin (NPM1) in acute myeloid leukemia (AML): association with other gene abnormalities and previously established gene expression signatures and their favorable prognostic significance.","volume":"106","author":"Verhaak","year":"2005","journal-title":"Blood"},{"key":"2019111712581273300_B7","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.immuni.2004.11.006","article-title":"Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C\/EBP alpha.","volume":"21","author":"Zhang","year":"2004","journal-title":"Immunity"},{"key":"2019111712581273300_B8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1073\/pnas.94.2.569","article-title":"Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice.","volume":"94","author":"Zhang","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111712581273300_B9","doi-asserted-by":"crossref","first-page":"4301","DOI":"10.1128\/MCB.18.7.4301","article-title":"CCAAT\/enhancer binding protein alpha is a regulatory switch sufficient for induction of granulocytic development from bipotential myeloid progenitors.","volume":"18","author":"Radomska","year":"1998","journal-title":"Mol Cell Biol"},{"key":"2019111712581273300_B10","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/nrc1363","article-title":"C\/EBPalpha mutations in acute myeloid leukaemias.","volume":"4","author":"Nerlov","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"2019111712581273300_B11","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/86515","article-title":"AML1-ETO downregulates the granulocytic differentiation factor C\/EBPalpha in t(8;21) myeloid leukemia.","volume":"7","author":"Pabst","year":"2001","journal-title":"Nat Med"},{"key":"2019111712581273300_B12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ng791","article-title":"BCR-ABL suppresses C\/EBPalpha expression through inhibitory action of hnRNP E2.","volume":"30","author":"Perrotti","year":"2002","journal-title":"Nat Genet"},{"key":"2019111712581273300_B13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nri2024","article-title":"Transcription factors in myeloid development: balancing differentiation with transformation.","volume":"7","author":"Rosenbauer","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"2019111712581273300_B14","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood-2003-06-1978","article-title":"Internal tandem duplication mutation of FLT3 blocks myeloid differentiation through suppression of C\/EBPalpha expression.","volume":"103","author":"Zheng","year":"2004","journal-title":"Blood"},{"key":"2019111712581273300_B15","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ccr.2006.09.012","article-title":"Tribbles homolog 2 inactivates C\/EBPalpha and causes acute myelogenous leukemia.","volume":"10","author":"Keeshan","year":"2006","journal-title":"Cancer Cell"},{"key":"2019111712581273300_B16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/ni1045","article-title":"Notch regulation of lymphocyte development and function.","volume":"5","author":"Radtke","year":"2004","journal-title":"Nat Immunol"},{"key":"2019111712581273300_B17","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia.","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"2019111712581273300_B18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrc1880","article-title":"Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia.","volume":"6","author":"Grabher","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2019111712581273300_B19","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1080\/10428190600773339","article-title":"NOTCH1 mutations are rare in acute myeloid leukemia.","volume":"47","author":"Fu","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"2019111712581273300_B20","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1038\/sj.leu.2404409","article-title":"Activating mutations in NOTCH1 in acute myeloid leukemia and lineage switch leukemias.","volume":"20","author":"Palomero","year":"2006","journal-title":"Leukemia"},{"key":"2019111712581273300_B21","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1182\/blood-2005-08-3329","article-title":"Recent insights into the role of Notch signaling in tumorigenesis.","volume":"107","author":"Leong","year":"2006","journal-title":"Blood"},{"key":"2019111712581273300_B22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.thj.6200216","article-title":"Biallelic mutations in the CEBPA gene and low CEBPA expression levels as prognostic markers in intermediate-risk AML.","volume":"4","author":"Barjesteh van Waalwijk van Doorn-Khosrovani","year":"2003","journal-title":"Hematol J"},{"key":"2019111712581273300_B23","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98\u20133936.","volume":"17","author":"van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"2019111712581273300_B24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/35004599","article-title":"A clonogenic common myeloid progenitor that gives rise to all myeloid lineages.","volume":"404","author":"Akashi","year":"2000","journal-title":"Nature"},{"key":"2019111712581273300_B25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/ni1354","article-title":"C\/EBPbeta is required for \u2018emergency\u2019 granulopoiesis.","volume":"7","author":"Hirai","year":"2006","journal-title":"Nat Immunol"},{"key":"2019111712581273300_B26","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1101\/gad.1450406","article-title":"c-Myc is an important direct target of Notch1 in T-cell acute lymphoblastic leukemia\/lymphoma.","volume":"20","author":"Weng","year":"2006","journal-title":"Genes Dev"},{"key":"2019111712581273300_B27","doi-asserted-by":"crossref","first-page":"5116","DOI":"10.1073\/pnas.091062498","article-title":"Significance analysis of microarrays applied to the ionizing radiation response.","volume":"98","author":"Tusher","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111712581273300_B28","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1084\/jem.183.5.2283","article-title":"Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles.","volume":"183","author":"Pear","year":"1996","journal-title":"J Exp Med"},{"key":"2019111712581273300_B29","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.4049\/jimmunol.163.5.2576","article-title":"Signals transduced by CD3epsilon, but not by surface pre-TCR complexes, are able to induce maturation of an early thymic lymphoma in vitro.","volume":"163","author":"Carleton","year":"1999","journal-title":"J Immunol"},{"key":"2019111712581273300_B30","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.1073\/pnas.082099299","article-title":"Diagnosis of multiple cancer types by shrunken centroids of gene expression.","volume":"99","author":"Tibshirani","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111712581273300_B31","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1093\/jnci\/djj093","article-title":"Epigenetic modulation of tumor suppressor CCAAT\/enhancer binding protein alpha activity in lung cancer.","volume":"98","author":"Tada","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"2019111712581273300_B32","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1046\/j.1365-2141.2002.03952.x","article-title":"Infrequent hypermethylation of CEBPA promotor in acute myeloid leukaemia.","volume":"119","author":"Chim","year":"2002","journal-title":"Br J Haematol"},{"key":"2019111712581273300_B33","doi-asserted-by":"crossref","first-page":"3895","DOI":"10.1182\/blood-2006-08-040147","article-title":"The C\/EBP\u03b4 tumor suppressor is silenced by hypermethylation in acute myeloid leukemia.","volume":"109","author":"Agrawal","year":"2007","journal-title":"Blood"},{"key":"2019111712581273300_B34","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/sj.leu.2404128","article-title":"Cytogenetics, molecular and ultrastructural characteristics of biphenotypic acute leukemia identified by the EGIL scoring system.","volume":"20","author":"Owaidah","year":"2006","journal-title":"Leukemia"},{"key":"2019111712581273300_B35","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1046\/j.1365-2141.2003.04715.x","article-title":"Adult T-biphenotypic acute leukaemia: clinical and biological features and outcome.","volume":"123","author":"Rubio","year":"2003","journal-title":"Br J Haematol"},{"key":"2019111712581273300_B36","first-page":"699","article-title":"Outcome of biphenotypic acute leukemia.","volume":"84","author":"Killick","year":"1999","journal-title":"Haematologica"},{"key":"2019111712581273300_B37","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1182\/blood.V72.2.579.579","article-title":"Acute myeloid leukemia with T-lymphoid features: a distinct biologic and clinical entity.","volume":"72","author":"Cross","year":"1988","journal-title":"Blood"},{"key":"2019111712581273300_B38","first-page":"489","article-title":"Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significance.","volume":"7","author":"Drexler","year":"1993","journal-title":"Leukemia"},{"key":"2019111712581273300_B39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ajcp\/109.2.211","article-title":"The immunophenotype of adult acute myeloid leukemia: high frequency of lymphoid antigen expression and comparison of immunophenotype, French-American-British classification, and karyotypic abnormalities.","volume":"109","author":"Khalidi","year":"1998","journal-title":"Am J Clin Pathol"},{"key":"2019111712581273300_B40","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1158\/1078-0432.CCR-04-1552","article-title":"Risk assessment in patients with acute myeloid leukemia and a normal karyotype.","volume":"11","author":"Bienz","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2019111712581273300_B41","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1158\/1078-0432.CCR-04-1816","article-title":"Characterization of CEBPA mutations in acute myeloid leukemia: most patients with CEBPA mutations have biallelic mutations and show a distinct immunophenotype of the leukemic cells.","volume":"11","author":"Lin","year":"2005","journal-title":"Clin Cancer Res"},{"key":"2019111712581273300_B42","first-page":"1783","article-title":"Proposals for the immunological classification of acute leukemias: European Group for the Immunological Characterization of Leukemias (EGIL).","volume":"9","author":"Bene","year":"1995","journal-title":"Leukemia"},{"key":"2019111712581273300_B43","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1073\/pnas.0510304103","article-title":"Antagonistic effect of CCAAT enhancer-binding protein-alpha and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors.","volume":"103","author":"Hsu","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111712581273300_B44","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1093\/emboj\/cdg380","article-title":"Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C\/EBPalpha and GATA factors.","volume":"22","author":"Heavey","year":"2003","journal-title":"EMBO J"},{"key":"2019111712581273300_B45","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0092-8674(04)00419-2","article-title":"Stepwise reprogramming of B cells into macrophages.","volume":"117","author":"Xie","year":"2004","journal-title":"Cell"},{"key":"2019111712581273300_B46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/35030112","article-title":"Cell-fate conversion of lymphoid-committed progenitors by instructive actions of cytokines.","volume":"407","author":"Kondo","year":"2000","journal-title":"Nature"},{"key":"2019111712581273300_B47","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1038\/sj.emboj.7601199","article-title":"Comprehensive analysis of myeloid lineage conversion using mice expressing an inducible form of C\/EBPalpha.","volume":"26","author":"Fukuchi","year":"2006","journal-title":"EMBO J"},{"key":"2019111712581273300_B48","doi-asserted-by":"crossref","first-page":"3560","DOI":"10.1182\/blood-2006-03-010835","article-title":"Overexpression of CEBPA resulting from the translocation t(14;19)(q32;q13) of human precursor B acute lymphoblastic leukemia.","volume":"108","author":"Chapiro","year":"2006","journal-title":"Blood"},{"key":"2019111712581273300_B49","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1182\/blood-2006-08-041012","article-title":"Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL).","volume":"109","author":"Akasaka","year":"2007","journal-title":"Blood"},{"key":"2019111712581273300_B50","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/MCB.01655-05","article-title":"Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes.","volume":"26","author":"Malecki","year":"2006","journal-title":"Mol Cell Biol"},{"key":"2019111712581273300_B51","doi-asserted-by":"crossref","first-page":"6261","DOI":"10.1128\/MCB.02478-05","article-title":"Identification of a conserved negative regulatory sequence that influences the leukemogenic activity of NOTCH1.","volume":"26","author":"Chiang","year":"2006","journal-title":"Mol Cell Biol"},{"key":"2019111712581273300_B52","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1182\/blood-2006-08-041202","article-title":"Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis.","volume":"109","author":"Jin","year":"2007","journal-title":"Blood"},{"key":"2019111712581273300_B53","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/1521-4141(200104)31:4<1141::AID-IMMU1141>3.0.CO;2-R","article-title":"TARPP, a novel protein that accompanies TCR gene rearrangement and thymocyte education.","volume":"31","author":"Kisielow","year":"2001","journal-title":"Eur J Immunol"},{"key":"2019111712581273300_B54","doi-asserted-by":"crossref","first-page":"25339","DOI":"10.1074\/jbc.M402544200","article-title":"Loss of CARM1 results in hypomethylation of thymocyte cyclic AMP-regulated phosphoprotein and deregulated early T cell development.","volume":"279","author":"Kim","year":"2004","journal-title":"J Biol Chem"},{"key":"2019111712581273300_B55","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/nrm1433","article-title":"Alpha-catenin: at the junction of intercellular adhesion and actin dynamics.","volume":"5","author":"Kobielak","year":"2004","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2019111712581273300_B56","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.cell.2005.09.021","article-title":"Alpha-catenin is a molecular switch that binds E-cadherin-beta-catenin and regulates actin-filament assembly.","volume":"123","author":"Drees","year":"2005","journal-title":"Cell"},{"key":"2019111712581273300_B57","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nm1512","article-title":"Chromosome 5q deletion and epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation.","volume":"13","author":"Liu","year":"2007","journal-title":"Nat Med"},{"key":"2019111712581273300_B58","doi-asserted-by":"crossref","first-page":"3716","DOI":"10.1158\/1078-0432.CCR-06-0030","article-title":"Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers.","volume":"12","author":"Tang","year":"2006","journal-title":"Clin Cancer Res"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/110\/10\/3706\/1291452\/zh802207003706.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/110\/10\/3706\/1291452\/zh802207003706.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,13]],"date-time":"2023-05-13T13:02:02Z","timestamp":1683982922000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/110\/10\/3706\/23440\/Distinct-gene-expression-profiles-of-acute"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11,15]]},"references-count":58,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,11,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2007-02-073486","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,11,15]]}}}